Table 2 Potency and efficacy (β-arrestin recruitment) of I8-arachnotocin at human receptors.

From: I8-arachnotocin–an arthropod-derived G protein-biased ligand of the human vasopressin V2 receptor

 

I8-arachnotocin

OT/VP&

EC50

pEC50

Emax#

EC50

pEC50

Emax#

V2Rβ-arr1

n.d.

56 nM

−7.25 ± 0.07

100%

V2Rβ-arr2

n.d.

60 nM

−7.22 ± 0.07

100%

V1bR

1.2 µM

−5.92 ± 0.14

65 ± 5%

6.9 nM

−8.16 ± 0.09

100%

V1aR

n.d.

28 nM

−7.55 ± 0.12

100%

OTR

5.7 µM

−5.24 ± 0.26

32 ± 5%

170 nM

−6.77 ± 0.15

100%

  1. #EC50 is given in nM or µM (as indicated) and as pEC50 as logEC50 ± SEM.
  2. &controls were VP at V2R, V1aR, V1bR and OT at OTR; n.d., not detectable; β-arr, β-arrestin.